The best indicator for Huntington Bancshares (HBAN)
We backtested 20 indicators across daily, weekly and hourly charts on real Huntington Bancshares (HBAN) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
EMA 50/200 Cross
On the daily chart, this is the strongest risk-adjusted edge we found for Huntington Bancshares (HBAN) over ~46.2 years — trailing buy-and-hold by 1.6% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | EMA 50/200 Cross ✓ | Daily | 6.6% | 0.41 | -55.1% | 50.0% | 26 | -1.6% |
| 2 | Stochastic ✓ | Daily | 7.0% | 0.37 | -82.8% | 70.9% | 230 | -1.2% |
| 3 | Williams %R ✓ | Daily | 6.1% | 0.35 | -65.9% | 70.1% | 298 | -2.1% |
| 4 | EMA 20/50 Cross ✓ | Weekly | 5.2% | 0.34 | -57.4% | 63.6% | 22 | -3.0% |
| 5 | SMA 50/200 Cross ✓ | Daily | 4.5% | 0.31 | -59.5% | 40.5% | 37 | -3.7% |
| 6 | Rate of Change ✓ | Weekly | 5.2% | 0.31 | -75.9% | 45.6% | 160 | -3.0% |
| 7 | EMA 20/50 Cross ✓ | Daily | 4.7% | 0.3 | -69.4% | 43.0% | 121 | -3.5% |
| 8 | CCI ✓ | Weekly | 5.2% | 0.3 | -74.6% | 75.6% | 45 | -3.0% |
| 9 | Donchian Midline ✓ | Weekly | 3.9% | 0.28 | -74.0% | 47.3% | 129 | -4.3% |
| 10 | MACD ✓ | Weekly | 4.1% | 0.27 | -83.4% | 54.7% | 95 | -4.1% |
| 11 | Bollinger Breakout | Weekly | 3.2% | 0.27 | -61.6% | 57.8% | 45 | -5.0% |
| 12 | Holy Grail Confluence ✓ | Weekly | 4.4% | 0.27 | -82.0% | 86.7% | 15 | -3.8% |
| 13 | WaveTrend (8/6/4) ✓ | Weekly | 4.0% | 0.26 | -79.2% | 75.0% | 36 | -4.2% |
| 14 | WaveTrend (8/6/4) ✓ | Daily | 2.8% | 0.24 | -93.4% | 69.5% | 174 | -5.4% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Huntington Bancshares (HBAN), EMA 50/200 Cross on the daily timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.